granisetron + granisetron
ApprovedCompleted 0 watching 0 views this week🔥 Hot
85
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Post-Operative Nausea and Vomiting
Conditions
Post-Operative Nausea and Vomiting
Trial Timeline
Apr 1, 2007 → Dec 1, 2007
NCT ID
NCT00231478About granisetron + granisetron
granisetron + granisetron is a approved stage product being developed by Roche for Post-Operative Nausea and Vomiting. The current trial status is completed. This product is registered under clinical trial identifier NCT00231478. Target conditions include Post-Operative Nausea and Vomiting.
Hype Score Breakdown
Clinical
30
Activity
20
Company
10
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00231478 | Approved | Completed |
Competing Products
18 competing products in Post-Operative Nausea and Vomiting